Aperigon helps Life Sciences companies run better. We optimize your processes, manage your change, and drive your system decisions from selection through go-live — independent of every vendor, fluent in GxP and SOX alike, and built to engage in days, not quarters.
You're racing two clocks at once. Every month lost is a month less of patent exclusivity — and a month a competitor gains toward market with a similar or better therapy. Yet the firms that serve this market run on their own time: a big consultancy can take two or three months just to contract. For a company with a year to build manufacturing, gain approval, and stand up operations, that's a quarter of the runway spent procuring advice.
The alternatives have their own problem: the integrator's "free assessment" funnels toward their build revenue, and the compliance shop knows GxP but has never prepared for an SOX audit read an S-1. Aperigon was built against both failure modes — one senior advisor on your side of the table, independent of every vendor, fluent in the whole company you're becoming, and moving at the speed your clock demands.
NDA signable same day. Proposal within five business days of discovery. Signed to kickoff inside two weeks. The decision maker is in the room — not one committee and two partners removed — and there's no legacy bench of hundreds we have to keep busy.
No software. No implementation hours to protect. No reseller margin, no referral commissions. When we run a selection, the scorecard and the recorded rationale are the audit trail. Implementation partners build; we stay on your side of the table through execution.
The full operating surface — procurement, inventory, contracts, order-to-cash, planning — with GxP placed where it belongs and nowhere it doesn't. And because one therapy takes hundreds of millions — often $1–2 billion — to reach approval and launch, we design for what's next: SOX-ready controls, IPO-grade reporting, multi-entity global architecture from day one.
We work with pharma, biotech, medical device, and CDMO/CMO companies — typically 25 to 500 employees — whose processes, change load, or systems are starting to limit the science.
A few situations we know well:
The math is unforgiving: spend three of your twelve months contracting a consultancy and you've paid 25% of your available time before any work begins. So we publish our commitments instead of implying them:
Full-surface assessment — procurement to order-to-cash to quality — with a roadmap of what to fix first, and why.
Categorize, plan, and execute the change growth demands — regulatory, growth, and efficiency — so it actually sticks.
Vendor-agnostic requirements, scorecard, and recommendation — with the recorded rationale as your audit trail.
Client-side program management of the build — plan integrity, scope control, validation oversight — until go-live sticks.
One operating loop at any scale — a question answered in days or a program overseen for a year. Four lenses on every problem, named deliverables, and a decision you can defend — to your board, your auditor, or your inspector.
The grounding: where are we, what matters now — through four lenses: operations, regulatory, capital, global.
Prioritized roadmap, change portfolio, selection scorecard.
Client-side program management, change execution, validation oversight.
Adoption measurement, periodic reviews, advisory retainer.
We respond to every inbound personally, usually within a business day. No SDR queue. No discovery-call carousel. If we're not the right fit, we'll say so — and tell you who is.